Evidence map›Paper›PMID 27882349›Full record

ArticleJCI insight2016

The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer.

S M Jamshedur Rahman, Xiangming Ji, Lisa J Zimmerman, Ming Li, Bradford K Harris, Megan D Hoeksema, Irina A Trenary, Yong Zou, Jun Qian, Robbert Jc Slebos and 7 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. The impact of the lung EDRN-CVC on Phase 1, 2, & 3 biomarker validation studies.Cancer biomarkers : section A of Disease markers · 2022
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. COPD-Related Modification to the Airway Epithelium Permits Intracellular Residence of NontypeableInternational journal of chronic obstructive pulmonary disease · 2020
    Article
  17. Article
  18. Article
  19. Lipid metabolism in chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

S M Jamshedur RahmanDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Cancer Early Detection and Prevention Initiative, Vanderbilt Ingram Cancer Center.
Xiangming JiDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Cancer Early Detection and Prevention Initiative, Vanderbilt Ingram Cancer Center.
Lisa J ZimmermanDepartment of Biochemistry.
Ming LiDepartment of Biostatistics, and.
Bradford K HarrisDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Cancer Early Detection and Prevention Initiative, Vanderbilt Ingram Cancer Center.
Megan D HoeksemaDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Cancer Early Detection and Prevention Initiative, Vanderbilt Ingram Cancer Center.
Irina A TrenaryDepartment of Chemical and Biomolecular Engineering, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Yong ZouDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Cancer Early Detection and Prevention Initiative, Vanderbilt Ingram Cancer Center.
Jun QianDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Cancer Early Detection and Prevention Initiative, Vanderbilt Ingram Cancer Center.
Robbert Jc SlebosDepartment of Biochemistry.
Jennifer BeanePulmonary Center and Section of Computational Biomedicine, Department of Medicine, Boston University Medical Center, Boston, Massachusetts, USA.
Avrum SpiraPulmonary Center and Section of Computational Biomedicine, Department of Medicine, Boston University Medical Center, Boston, Massachusetts, USA.
Yu ShyrDepartment of Biostatistics, and.
Rosana EisenbergDepartments of Pathology, Microbiology, and Immunology.
Daniel C LieblerDepartment of Biochemistry.
Jamey D YoungDepartment of Chemical and Biomolecular Engineering, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Pierre P MassionDivision of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Cancer Early Detection and Prevention Initiative, Vanderbilt Ingram Cancer Center.
Vanderbilt-Ingram Cancer CenterCancer Research And Biostatistics · USBipar · FRInstitute of Molecular Biology and Biophysics · RU

Funding

Validation of Biomarkers of Risk for the Early Detection of Lung CancerU01CA152662 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DEPPEN, STEPHEN, GROGAN, ERIC L · 2010 to 2025
$12.8M
Vanberbilt Biomarker Developmental LaboratoryU01CA152647 · NCI · VANDERBILT UNIVERSITY · PI LIEBLER, DANIEL C, TABB, DAVID L · 2010 to 2014
$3.1M
Molecular Approaches to Early Detection of Lung CancerR01CA102353 · NCI · VANDERBILT UNIVERSITY · PI MASSION, PIERRE P. · 2005 to 2014
$2.4M
NCI NIH HHS R01 CA102353NCI NIH HHS U01 CA152647NCI NIH HHS U01 CA152662
6 · The paper itself

Abstract

The molecular determinants of lung cancer risk remain largely unknown. Airway epithelial cells are prone to assault by risk factors and are considered to be the primary cell type involved in the field of cancerization. To investigate risk-associated changes in the bronchial epithelium proteome that may offer new insights into the molecular pathogenesis of lung cancer, proteins were identified in the airway epithelial cells of bronchial brushing specimens from risk-stratified individuals by shotgun proteomics. Differential expression of selected proteins was validated by parallel reaction monitoring mass spectrometry in an independent set of individual bronchial brushings. We identified 2,869 proteins, of which 312 proteins demonstrated a trend in expression. Pathway analysis revealed enrichment of carbohydrate metabolic enzymes in high-risk individuals. Glucose consumption and lactate production were increased in human bronchial epithelial BEAS2B cells treated with cigarette smoke condensate for 7 months. Increased lipid biosynthetic capacity and net reductive carboxylation were revealed by metabolic flux analyses of [U-

Indexed as

BronchiCell LineEpithelial CellsGene Expression ProfilingHumansLipid MetabolismLung NeoplasmsMetabolomicsProteomeRespiratory MucosaSmokeSmokingProteomeSmoke

Identifiers

PMID27882349
PMCPMC5111517
OpenAlexW2553304061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.